MERISANT EUROPE
0471.239.064 · rovalta.com · 26/09/2026
MERISANT EUROPE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOMERISANT EUROPE is a Private limited company incorporated in 2000. Its main activity is: Manufacture of sugar. Its registered office is in Bruxelles.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0471.239.064
- Incorporation
- 25/02/2000
- Legal form
- Private limited company
- Registered office
- Place des Barricades 13
1000 Bruxelles · BruxellesSee on map - Contributed capital
- 120 000,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 207
Financials
Source · NBB, 21 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 67 k € | +54.4% | 43,4 k € | – | – | – | |||
| EBITDA | 66 k € | +61.5% | 40,9 k € | -50.5% | 82,5 k € | -51.2% | 169,2 k € | +29.9% | 130,2 k € |
| Operating result | 66 k € | +61.5% | 40,9 k € | -50.5% | 82,5 k € | -51.2% | 169,2 k € | +29.9% | 130,2 k € |
| Net result | 51,9 k € | +72.6% | 30,1 k € | -14.4% | 35,1 k € | -70.8% | 120,2 k € | +28.6% | 93,4 k € |
| Balance sheet | |||||||||
| Equity | 183,9 k € | -90.4% | 1,9 M € | +1.6% | 1,9 M € | +1.9% | 1,8 M € | +7.0% | 1,7 M € |
| Total assets | 1,1 M € | -42.6% | 2 M € | -8.5% | 2,1 M € | -1.1% | 2,2 M € | +9.2% | 2 M € |
| Cash | 22,4 k € | -58.2% | 53,5 k € | -14.7% | 62,8 k € | -93.0% | 901,2 k € | +97.3% | 456,8 k € |
| Debts | 935,1 k € | +4566% | 20 k € | -51.8% | 41,6 k € | -69.2% | 135 k € | +61.2% | 83,7 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20253 active · 31 ended
Active mandates
Ended mandates
Other companies at this address
Place des Barricades 13 1000 Bruxelles| Company | CBE no. |
|---|---|
ALBA HOLDING● Active | 1038.846.046 |
ARMED CELL THERAPEUTICS● Active | 1039.592.451 |
BIOQUBE FACTORY FUND I● Active | 0747.784.678 |
| 1016.717.178 | |
Bioqube Factory Fund II Privak● Active | 1016.385.497 |
Domein van Vorselaar● Active | 0423.793.790 |
EDWIN VERMULST● Active | 0862.424.030 |
Fibrocor Therapeutics Europe● Active | 1025.566.152 |
Orgues De Facto● Active | 0763.798.685 |
PETER KUGEL● Active | 0607.848.520 |
| 0400.488.749 | |
Société des Habitations à Bon Marché● Liquidation | 0403.363.117 |
Stoffels IMC● Active | 0780.918.294 |
VIPOWA● Active | 0886.120.437 |
VVGB 2016● Active | 0654.806.418 |
VVGB Advocaten fv● Active | 0525.904.504 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 16/07/2026 | 03/07/2025 | 08/07/2024 | 03/07/2023 | 20/07/2022 | 12/07/2021 |
| General meeting | 30/06/2026 | 27/06/2025 | 26/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 21 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 16/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 27/06/2025 | 03/07/2025 | Dutch | |
| Full model | 31/12/2023 | 26/06/2024 | 08/07/2024 | Dutch | |
| Full model | 31/12/2022 | 30/06/2023 | 03/07/2023 | Dutch | |
| Full model | 31/12/2021 | 30/06/2022 | 20/07/2022 | Dutch | |
| Full model | 31/12/2020 | 30/06/2021 | 12/07/2021 | Dutch | |
| Full model | 31/12/2019 | 30/06/2020 | 08/07/2020 | Dutch | |
| Full model | 31/12/2018 | 26/06/2019 | 19/07/2019 | Dutch | |
| Full model | 31/12/2017 | 26/06/2018 | 18/07/2018 | Dutch | |
| Full model | 31/12/2016 | 26/06/2017 | 04/07/2017 | Dutch | |
| Full modelCorrection | 31/12/2015 | 26/06/2016 | 13/06/2017 | Dutch | |
| Full model | 31/12/2015 | 26/06/2016 | 01/07/2016 | Dutch | |
| Full model | 31/12/2014 | 26/06/2015 | 08/07/2015 | Dutch | |
| Full model | 31/12/2013 | 19/06/2014 | 25/06/2014 | Dutch | |
| Full model | 31/12/2012 | 19/06/2013 | 02/07/2013 | Dutch | |
| Full model | 31/12/2011 | 20/06/2012 | 27/06/2012 | Dutch | |
| Full model | 31/12/2010 | 06/06/2011 | 15/06/2011 | Dutch | |
| Full model | 31/12/2009 | 16/06/2010 | 16/06/2010 | Dutch | |
| Full model | 31/12/2008 | 02/06/2009 | 26/06/2009 | Dutch | |
| Full model | 31/12/2007 | 02/06/2008 | 08/07/2008 | Dutch | |
| Full model | 31/12/2006 | 11/06/2007 | 19/06/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 31 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates09/07/2025ONTSLAGEN - BENOEMINGEN
- Mandates13/03/2024ONTSLAGEN - BENOEMINGEN
- Mandates02/08/2023ONTSLAGEN - BENOEMINGEN
- Mandates30/05/2023ONTSLAGEN - BENOEMINGEN
- Mandates17/11/2022ONTSLAGEN - BENOEMINGEN
- Mandates20/09/2021ONTSLAGEN - BENOEMINGEN
- Mandates01/03/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Mandates01/03/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202551,9 k €↑
- 2024Annual accounts 202430,1 k €↓
- 2023Annual accounts 202335,1 k €↓
- 2022Annual accounts 2022120,2 k €↑
- 2021Annual accounts 202193,4 k €↑
- 2020Annual accounts 202044,5 k €↓
- 2019Annual accounts 201949,1 k €↓
- 2018Annual accounts 201851,9 k €↑
- 2017Annual accounts 201735,7 k €↓
- 2016Annual accounts 201647,4 k €↓
- 2015Annual accounts 201552,7 k €↑
- 2014Annual accounts 201444,2 k €↓
- 2013Annual accounts 201373,1 k €↓
- 2012Annual accounts 201294,9 k €↑
- 2011Annual accounts 2011-9 k €↓
- 2010Annual accounts 201028,3 k €↓
- 2009Annual accounts 200933,7 k €↓
- 2008Annual accounts 200851,7 k €↓
- 2007Annual accounts 2007166,6 k €↑
- 2006Annual accounts 200612,2 k €
- 25/02/2000IncorporationPrivate limited company